Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 11, Pages 5898-5906
Publisher
American Society for Microbiology
Online
2012-09-05
DOI
10.1128/aac.01115-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine
- (2012) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility
- (2012) Shawn R. Lockhart et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Extensive Genetic Diversity within the Dutch Clinical Cryptococcus neoformans Population
- (2012) Ferry Hagen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Correlation of antifungal susceptibility and molecular type within theCryptococcus neoformans/C. gattiispecies complex
- (2012) Luciana Trilles et al. MEDICAL MYCOLOGY
- Resistance of Asian Cryptococcus neoformans Serotype A Is Confined to Few Microsatellite Genotypes
- (2012) Weihua Pan et al. PLoS One
- Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates Obtained through Population-Based Surveillance in South Africa in 2002-2003 and 2007-2008
- (2011) Nelesh P. Govender et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of a Cryptococcus neoformans Cytochrome P450 Lanosterol 14α-Demethylase (Erg11) Residue Critical for Differential Susceptibility between Fluconazole/Voriconazole and Itraconazole/Posaconazole
- (2011) Edward Sionov et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Caspofungin and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2011) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen
- (2011) J. R. Harris et al. CLINICAL INFECTIOUS DISEASES
- Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method
- (2011) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India
- (2011) A. Chowdhary et al. JOURNAL OF MEDICAL MICROBIOLOGY
- A Diverse Population of Cryptococcus gattii Molecular Type VGIII in Southern Californian HIV/AIDS Patients
- (2011) Edmond J. Byrnes et al. PLoS Pathogens
- Heteroresistance of Cryptococcus gattii to Fluconazole
- (2010) A. Varma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates
- (2010) F. Hagen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
- (2010) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
- (2010) A. Espinel-Ingroff et al. JOURNAL OF CLINICAL MICROBIOLOGY
- In Vitro Susceptibility of the Yeast Pathogen Cryptococcus to Fluconazole and Other Azoles Varies with Molecular Genotype
- (2010) H. S. Chong et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mixed Infections and In Vivo Evolution in the Human Fungal Pathogen Cryptococcus neoformans
- (2010) M. Desnos-Ollivier et al. mBio
- Emergence and Pathogenicity of Highly Virulent Cryptococcus gattii Genotypes in the Northwest United States
- (2010) Edmond J. Byrnes et al. PLoS Pathogens
- Three-Dimensional Model of Lanosterol 14 -Demethylase from Cryptococcus neoformans: Active-Site Characterization and Insights into Azole Binding
- (2009) C. Sheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints
- (2009) A. Dalhoff et al. INFECTION
- Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Genotyping of MexicanCryptococcus neoformansandC. gattiiisolates by PCR-fingerprinting
- (2009) L. R. Castañón Olivares et al. MEDICAL MYCOLOGY
- Diversidad del complejo de especies Cryptococcus neoformans-Cryptococcus gattii
- (2009) Marjan Bovers et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentosos
- (2009) Ana Espinel-Ingroff REVISTA IBEROAMERICANA DE MICOLOGIA
- Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
- (2008) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba
- (2008) M.-T. Illnait-Zaragozi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatus
- (2008) J. L. Rodriguez-Tudela et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro susceptibility of Cryptococcus gattii clinical isolates
- (2008) A. Gomez-Lopez et al. CLINICAL MICROBIOLOGY AND INFECTION
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now